These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17355414)

  • 41. Extra-hepatic embolisation of Y-90 microspheres from selective internal radiation therapy (SIRT) of the liver.
    Thamboo Tp; Tan KB; Wang SC; Salto-Tellez M
    Pathology; 2003 Aug; 35(4):351-3. PubMed ID: 12959774
    [No Abstract]   [Full Text] [Related]  

  • 42. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics.
    Salem R; Thurston KG
    J Vasc Interv Radiol; 2006 Sep; 17(9):1425-39. PubMed ID: 16990462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radioembolization in patients with hepatic metastases from breast cancer.
    Jakobs TF; Hoffmann RT; Fischer T; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Reiser MF; Helmberger TK
    J Vasc Interv Radiol; 2008 May; 19(5):683-90. PubMed ID: 18440456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Superiority of proximal embolization of the gastroduodenal artery with the Amplatzer vascular plug 4 before yttrium-90 radioembolization: a retrospective comparison with coils in 134 patients.
    Bulla K; Hubich S; Pech M; Löwenthal D; Ricke J; Dudeck O
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):396-404. PubMed ID: 23842683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatobiliary effects of 90yttrium microsphere therapy for unresectable hepatocellular carcinoma.
    Nalesnik MA; Federle M; Buck D; Fontes P; Carr BI
    Hum Pathol; 2009 Jan; 40(1):125-34. PubMed ID: 18799190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].
    Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G
    Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Arterial radioembolization of malignant liver tumors by yttrium-90 microspheres].
    Tarazov PG
    Vopr Onkol; 2013; 59(4):428-34. PubMed ID: 24032215
    [No Abstract]   [Full Text] [Related]  

  • 48. Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma.
    Dawson LA
    J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):161-4. PubMed ID: 15713916
    [No Abstract]   [Full Text] [Related]  

  • 49. (90)Y radioembolization: embolization of the gastroduodenal artery is not always appropriate.
    Haydar AA; Wasan H; Wilson C; Tait P
    Cardiovasc Intervent Radiol; 2010 Oct; 33(5):1069-71. PubMed ID: 20379717
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical practice in radioembolization of hepatic malignancies: a survey among interventional centers in Europe.
    Powerski MJ; Scheurig-Münkler C; Banzer J; Schnapauff D; Hamm B; Gebauer B
    Eur J Radiol; 2012 Jul; 81(7):e804-11. PubMed ID: 22546235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors.
    Riaz A; Lewandowski RJ; Kulik L; Salem R
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):311-6. PubMed ID: 19521310
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comments on "Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer" by Cao et al, Chin Med J 1999; 112: 430-432.
    Ho S; Lau WY; Leung WT
    Chin Med J (Engl); 2001 Apr; 114(4):433-4. PubMed ID: 11780473
    [No Abstract]   [Full Text] [Related]  

  • 53. Severe coagulopathy after 90Y microsphere administration: resemblance to the Kasabach-Merritt syndrome.
    Hoffman MA; Rubin JI; Vinceguerra VP; Nowakowski FS; Warner RR
    J Vasc Interv Radiol; 2008 Jul; 19(7):1099-102. PubMed ID: 18589326
    [No Abstract]   [Full Text] [Related]  

  • 54. Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization.
    Gaba RC; Lewandowski RJ; Kulik LM; Riaz A; Ibrahim SM; Mulcahy MF; Ryu RK; Sato KT; Gates V; Abecassis MM; Omary RA; Baker TB; Salem R
    Ann Surg Oncol; 2009 Jun; 16(6):1587-96. PubMed ID: 19357924
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.
    Kennedy A; Nag S; Salem R; Murthy R; McEwan AJ; Nutting C; Benson A; Espat J; Bilbao JI; Sharma RA; Thomas JP; Coldwell D
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):13-23. PubMed ID: 17448867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microspheres for radioembolization of liver malignancies.
    Vente MA; Zonnenberg BA; Nijsen JF
    Expert Rev Med Devices; 2010 Sep; 7(5):581-3. PubMed ID: 20822380
    [No Abstract]   [Full Text] [Related]  

  • 57. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
    Young JY; Rhee TK; Atassi B; Gates VL; Kulik L; Mulcahy MF; Larson AC; Ryu RK; Sato KT; Lewandowski RJ; Omary RA; Salem R
    J Vasc Interv Radiol; 2007 Nov; 18(11):1375-82. PubMed ID: 18003987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
    Ibrahim SM; Mulcahy MF; Lewandowski RJ; Sato KT; Ryu RK; Masterson EJ; Newman SB; Benson A; Omary RA; Salem R
    Cancer; 2008 Oct; 113(8):2119-28. PubMed ID: 18759346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term follow-up study of gastroduodenal lesions after radioembolization of hepatic tumors.
    Rodríguez-Lago I; Carretero C; Herráiz M; Subtil JC; Betés M; Rodríguez-Fraile M; Sola JJ; Bilbao JI; Muñoz-Navas M; Sangro B
    World J Gastroenterol; 2013 May; 19(19):2935-40. PubMed ID: 23704826
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radioembolization for treatment of liver metastases from neuroendocrine tumors: correlation with imaging and biomarkers.
    Ozao-Choy J; Friedman ML; Kim AS; Wachsman A; Wolin EM; Yu R; Nissen NN; Colquhoun SD
    Pancreas; 2013 Mar; 42(2):358-60. PubMed ID: 23407486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.